3

PRIMARY DOCUMENT

Company: ATOSSA THERAPEUTICS, INC.
Filed: January 10, 2013
Period of Report: January 4, 2013
Accession Number: 0000904454-13-000012

View Document ↗ View on SEC.gov ↗